Albuquerque, NM, United States of America

Constantine I Andreev

This inventor holds 1 USPTO granted patent. Top assignee: Intellicyt Corporation. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Constantine I Andreev

Introduction

Constantine I Andreev is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of flow cytometry, particularly in the area of sample separation methods and apparatus. His work has implications for various scientific and medical applications.

Latest Patents

Andreev holds a patent for "Flow cytometry sample separation methods and apparatus." This innovative method involves identifying sample boundaries of multiple samples by moving them into a fluid flow stream using a sampling probe. The introduction of marker beads into the fluid flow stream helps to separate the samples effectively. This technique enhances the accuracy and efficiency of sample analysis in flow cytometry.

Career Highlights

Andreev is associated with Intellicyt Corporation, where he has been instrumental in advancing technologies related to flow cytometry. His expertise in this area has contributed to the development of more precise and reliable methods for analyzing biological samples.

Collaborations

Throughout his career, Andreev has collaborated with talented individuals such as Matthew Hess and Joe Zock. These partnerships have fostered innovation and have led to the successful development of new technologies in the field.

Conclusion

Constantine I Andreev's contributions to flow cytometry and his innovative patent demonstrate his commitment to advancing scientific research. His work continues to impact the field positively, paving the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…